PERCEPTIVE INFORMATICS APPOINTS LEADING IMAGING EXPERT DR. KENNETH G. FAULKNER TO VICE PRESIDENT OF MEDICAL IMAGING
BOSTON, MA, July 28, 2008 – Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation (NASDAQ: PRXL), a leading global biopharmaceutical services organization, announced today that it has appointed Kenneth G. Faulkner, Ph.D., to the position of Vice President of Medical Imaging. Dr. Faulkner, who has 22 years of experience in the application of specialized medical imaging techniques in support of biopharmaceutical product development, will oversee medical imaging worldwide.
“Biopharmaceutical companies are increasingly using our novel medical imaging analyses as biomarkers or surrogate endpoints to assess safety and efficacy. Dr. Faulkner’s in-depth experience will further strengthen Perceptive Informatics’ medical imaging capabilities to help clients accelerate decisions about the development of new treatments,” said Todd A. Joron, Corporate Vice President and General Manager of Perceptive Informatics at PAREXEL International.
Dr. Faulkner commented, “Perceptive Informatics is a clear leader in the field of medical imaging in support of clinical research, especially through the combination of its in-depth therapeutic expertise and advanced imaging technologies. I am excited to work with this high caliber global team and contribute my experience to help clients in the design and execution of their clinical studies across a broad range of therapeutic areas.”
Prior to joining PAREXEL, Dr. Faulkner was Vice President of Scientific Services at Synarc, a provider of centralized imaging, molecular markers, and clinical research facilities, which he helped to found in 1998. Previously, he was Chief Scientist and Director of Marketing and Product Development for the Lunar Densitometry business unit of GE Healthcare that is dedicated to bone health. Dr. Faulkner received his Ph.D. in Biomedical Engineering from the University of California, Berkeley and San Francisco. Dr. Faulkner holds three patents related to the use of medical imaging for the assessment of osteoporosis, and has published over 70 scientific articles in the areas of osteoporosis diagnosis and treatment. He has served on the Boards of Directors of the International Society of Clinical Densitometry and Oregon Board of Radiologic Technology, and has participated as an advisor to the U.S. Food and Drug Administration Center for Devices and Radiological Health (CDRH).
The Perceptive Informatics Medical Imaging Division provides specialized services for clinical study sponsors who increasingly rely on medical imaging as a surrogate endpoint in assessing the efficacy and safety of new products. Perceptive Informatics radiology experts provide a range of capabilities in the application of imaging techniques from early clinical development through peri-approval studies. The medical imaging team operates globally and services a wide range of therapeutic areas, including oncology, central nervous system, musculoskeletal, cardiovascular, and metabolism/endocrinology imaging.
PAREXEL and IMPACT are registered trademarks of PAREXEL International Corporation, and PERCEPTIVE INFORMATICS is a registered trademark of Perceptive Informatics, Inc. All other names or marks may be registered trademarks or trademarks of their respective business and are hereby acknowledged.